Results 1 to 10 of about 23,386 (218)

Peritoneal carcinomatosis [PDF]

World Journal of Gastroenterology, 2013
Several gastrointestinal and gynecological malignancies have the potential to disseminate and grow in the peritoneal cavity. The occurrence of peritoneal carcinomatosis (PC) has been shown to significantly decrease overall survival in patients with liver
Ansaloni L, BAIOCCHI, Gian Luca, Catena F., Coccolini F, Ghermandi C, GHEZA, Federico, GIULINI, Stefano Maria, Iusco D, Lotti M, Melotti R, Virzì S   +10 more
core   +7 more sources

PERITONEAL CARCINOMATOSIS

Сибирский онкологический журнал, 2016
The literature review examines the main pathological and morphogenetic aspects of the development of peritoneal carcinomatosis and its molecular and biological features.
I. V. Stepanov, Yu. М. Paderov, S. G. Afanasyev   +2 more
doaj   +5 more sources

Abdominal Sarcoidosis Mimicking Peritoneal Carcinomatosis [PDF]

Annals of Coloproctology, 2018
We present a patient diagnosed with skin sarcoidosis, breast cancer, pulmonary tuberculosis, and peritoneal sarcoidosis with a past history of colorectal cancer.
Won Seok Roh, Seungho Lee, Ji Hyun Park, Jeonghyun Kang   +3 more
doaj   +5 more sources

Intraperitoneal administration of mRNA encoding interleukin-12 for immunotherapy in peritoneal carcinomatosis [PDF]

Journal of Nanobiotechnology
Peritoneal carcinomatosis is an advanced stage of cancer with very limited treatment options. Locoregional immunotherapy is being evaluated as a way to improve efficacy and limit toxicity.
Leire Arrizabalaga, Claudia Augusta Di Trani, Myriam Fernández-Sendin, Ángela Bella, Joan Salvador Russo-Cabrera, Celia Gomar, Nuria Ardaiz, Virginia Belsue, José González-Gomariz, Sara Zalba, Adrián Gil-Korilis, Maria J. Garrido, Ignacio Melero, Fernando Aranda, Pedro Berraondo   +14 more
doaj   +2 more sources

Can inter-observer consistency be achieved in the laparoscopic assessment of the peritoneal carcinomatosis index score in peritoneal metastasis? A pilot study [PDF]

Pleura and Peritoneum
The main prognostic factor for peritoneal metastasis (PM) is the complete resection of the disease during cytoreductive surgery. Accurate patient selection is therefore essential for determining eligibility for this type of surgery.
Astruc Audrey, Seegers Valérie, Dumont Frederic, Loaec Cécile, Thibaudeau Emilie, Bourgin Charlotte, Wernert Romuald, Body Noémie, De Franco Valeria   +8 more
doaj   +2 more sources

Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC

World Journal of Surgical Oncology, 2023
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) improve the survival of selected patients with peritoneal metastasis. A major cause of treatment-related morbidity after CRS/HIPEC is infection and sepsis. HIPEC
Lilian Roth, Dilmurodjon Eshmuminov, Linda Russo, Felix Laminger, Friedrich Kober, Sebastian Roka, Kuno Lehmann   +6 more
doaj   +1 more source

New views on pathogenesis and diagnosis of peritoneal carcinomatosis

Креативная хирургия и онкология, 2023
Peritoneal metastasis occurs in a number of heterogeneous tumors originating from the ovaries, stomach, intestines, pancreas, lungs, breast, and melanoma. Peritoneal carcinomatosis significantly reduces overall survival.
K. R. Ishmuratova, K. Sh. Gantsev
doaj   +1 more source

Long-term results and prognostic factors of gastric cancer patients with microscopic peritoneal carcinomatosis. [PDF]

PLoS ONE, 2012
BACKGROUND: Clinical significance of microscopic peritoneal carcinomatosis remained unclear. The aim of this study was to evaluate the prognostic value of microscopic peritoneal carcinomatosis in gastric cancer.
Xiaowen Liu, Hong Cai, Weiqi Sheng, Yanong Wang   +3 more
doaj   +1 more source

Utility of ascitic tumor markers and adenosine deaminase for differential diagnosis of tuberculous peritonitis and peritoneal carcinomatosis

BMC Gastroenterology, 2022
Background Differential diagnosis between tuberculous peritonitis and peritoneal carcinomatosis remains challenging in clinical practice; thus, in-patients diagnosed with tuberculous peritonitis or peritoneal carcinomatosis were retrospectively enrolled,
Li Du, Xiuqi Wei, Zhuanglong Xiao, Hui Wang, Yuhu Song   +4 more
doaj   +1 more source

BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis [PDF]

, 2015
Background: Selected patients with peritoneal carcinomatosis (PC) from colorectal cancer (CRC) benefit from cytoreductive surgery (CRS) combined with intraperitoneal chemoperfusion (IPC).
Ceelen, Wim, Liberale, Gabriel, Van Der Speeten, Kurt, Willaert, Wouter   +3 more
core   +4 more sources